BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19739019)

  • 1. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.
    Takayama K; Torashima T
    J Neurovirol; 2009 Sep; 15(5-6):371-9. PubMed ID: 19739019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors.
    Manic G; Maurin-Marlin A; Galluzzi L; Subra F; Mouscadet JF; Bury-Moné S
    Hum Gene Ther Methods; 2012 Apr; 23(2):84-97. PubMed ID: 22456436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Nuclease-Directed Integration of Lentivirus Vectors into the Human Ribosomal DNA Locus.
    Schenkwein D; Afzal S; Nousiainen A; Schmidt M; Ylä-Herttuala S
    Mol Ther; 2020 Aug; 28(8):1858-1875. PubMed ID: 32504545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors.
    Shaw AM; Joseph GL; Jasti AC; Sastry-Dent L; Witting S; Cornetta K
    Gene Ther; 2017 Jan; 24(1):12-20. PubMed ID: 27682478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
    Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.
    Kantor B; Bayer M; Ma H; Samulski J; Li C; McCown T; Kafri T
    Mol Ther; 2011 Mar; 19(3):547-56. PubMed ID: 21157436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The murine stem cell virus promoter drives correlated transgene expression in the leukocytes and cerebellar Purkinje cells of transgenic mice.
    Oue M; Handa H; Matsuzaki Y; Suzue K; Murakami H; Hirai H
    PLoS One; 2012; 7(11):e51015. PubMed ID: 23226450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vectors with CMV or MHCII promoters administered in vivo: immune reactivity versus persistence of expression.
    Kimura T; Koya RC; Anselmi L; Sternini C; Wang HJ; Comin-Anduix B; Prins RM; Faure-Kumar E; Rozengurt N; Cui Y; Kasahara N; Stripecke R
    Mol Ther; 2007 Jul; 15(7):1390-9. PubMed ID: 17505480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.
    Scholz SJ; Fronza R; Bartholomä CC; Cesana D; Montini E; von Kalle C; Gil-Farina I; Schmidt M
    Hum Gene Ther; 2017 Oct; 28(10):875-885. PubMed ID: 28825370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.
    Schmidt M; Hoffmann G; Wissler M; Lemke N; Müssig A; Glimm H; Williams DA; Ragg S; Hesemann CU; von Kalle C
    Hum Gene Ther; 2001 May; 12(7):743-9. PubMed ID: 11339891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High transgene expression by lentiviral vectors causes maldevelopment of Purkinje cells in vivo.
    Sawada Y; Kajiwara G; Iizuka A; Takayama K; Shuvaev AN; Koyama C; Hirai H
    Cerebellum; 2010 Sep; 9(3):291-302. PubMed ID: 20178014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrase-defective lentiviral vectors: progress and applications.
    Banasik MB; McCray PB
    Gene Ther; 2010 Feb; 17(2):150-7. PubMed ID: 19847206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-inactivating lentiviral vectors with U3 and U5 modifications.
    Iwakuma T; Cui Y; Chang LJ
    Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Was cDNA sequences modulate transgene expression of was promoter-driven lentiviral vectors.
    Toscano MG; Benabdellah K; Muñoz P; Frecha C; Cobo M; Martín F
    Hum Gene Ther; 2009 Nov; 20(11):1279-90. PubMed ID: 19630517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.
    Knight S; Bokhoven M; Collins M; Takeuchi Y
    J Virol; 2010 May; 84(9):4856-9. PubMed ID: 20181689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
    Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
    Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual transgene expression in murine cerebellar Purkinje neurons by viral transduction in vivo.
    Bosch MK; Nerbonne JM; Ornitz DM
    PLoS One; 2014; 9(8):e104062. PubMed ID: 25093726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.
    Pelascini LP; Janssen JM; Gonçalves MA
    Hum Gene Ther; 2013 Jan; 24(1):78-96. PubMed ID: 23140481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
    Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
    Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.
    Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H
    Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.